$450 mn needed to tackle 'grave' malaria threat, WHO says

October 24, 2013

Hundreds of millions of dollars are needed to stop a deadly form of drug-resistant malaria jumping from Southeast Asia to the rest of the world, the World Health Organisation said Thursday.

Resistance to the anti- drug artemisinin has now been detected in Myanmar and Vietnam, the WHO said, five years after it warned that the drug was no longer effective in treating the disease on the Cambodia-Thailand border.

"The emergence of artemisinin resistance could undo the enormous progress made towards and elimination —- and potentially pose a serious global health threat," regional director Shin Young-Soo said in a statement.

"Key development partners strongly support our efforts. However, we still face a funding gap of at least $450 million over the next three years."

Malaria, which is caused by a parasite infecting mosquitos that feed on humans, kills 660,000 people each year, according to WHO figures.

Artemisinin-based therapies are the first-line treatment for cases of malaria caused by Plasmodium falciparum, the deadliest strain of the disease.

The drug is credited for the remarkable success in reducing the number of malaria deaths globally in recent years.

"If resistance to artemisinin emerges elsewhere, the consequences for could be grave," Shin said.

He said the drug-resistant strain was now found in four of the six states that make up Asia's Greater Mekong region, which also includes Laos and China's Yunnan province.

Resistance to the drug may have been caused by the parasite's long exposure to therapies, as well as "substandard or counterfeit" drugs in circulation, the WHO said.

Resistance to other formerly effective malaria drugs had also originated along the Cambodia-Thailand border, before spreading west to South Asia, then Africa where most malaria deaths occur, it added.

Malaria also remains a problem in Malaysia, Papua New Guinea, the Philippines, the Solomon Islands, South Korea and Vanuatu.

The warning came as senior health officials from East Asia and the Western Pacific met in Manila this week to coordinate support for international efforts to contain malaria and other diseases.

Shin said the Swiss-based Global Fund to Fight AIDS, Tuberculosis and Malaria had pledged US$100 million to the campaign to prevent the spread of drug-resistant malaria, which was also backed by Australia and the Bill and Melinda Gates Foundation.

Explore further: WHO urges action as drug-resistant malaria spreads

Related Stories

WHO urges action as drug-resistant malaria spreads

September 27, 2012
The World Health Organization said Thursday that governments in the Mekong region must act "urgently" to stop the spread of drug-resistant malaria which has emerged in parts of Vietnam and Myanmar.

Asia battles drug-resistant malaria

October 31, 2012
Drug-resistant malaria is spreading in Asia, experts warned as a high-level conference opened Wednesday with the aim of hammering out an action plan to strengthen the region's response.

WHO hopeful drug-resistant malaria can be contained

April 24, 2012
The World Health Organisation said Tuesday it was optimistic drug-resistant malaria that has emerged along Thailand's borders with Cambodia and Myanmar could be contained within the region.

Australia gives $104 million to fighting malaria

November 2, 2012
(AP)—Australia will spend more than 100 million Australian dollars ($104 million) over the next four years to help reduce deaths from malaria in the Asia-Pacific region.

Gene clues point to Cambodia for resistant malaria

April 28, 2013
Gene analysis of malaria parasites has pinpointed western Cambodia as the hotspot of strains that are dangerously resistant to artesiminin, the frontline drug against the disease, scientists said on Sunday.

Recommended for you

A new approach to developing a vaccine against vivax malaria

September 21, 2018
A novel study reports an innovative approach for developing a vaccine against Plasmodium vivax, the most prevalent human malaria parasite outside sub-Saharan Africa. The study led by Hernando A. del Portillo and Carmen Fernandez-Becerra, ...

Pre-clinical success for a universal flu vaccine offers hope for third generation approach

September 21, 2018
Researchers from the University of Oxford's Department of Zoology have demonstrated pre-clinical success for a universal flu vaccine in a new paper published in Nature Communications.

Fighting a deadly parasite: Scientists devise a method to store Cryptosporidium, aiding vaccine research efforts

September 21, 2018
In May, just before one of the hottest summers on record, the U.S. Centers for Disease Control and Prevention issued a warning about diseases lurking in recreational water facilities like swimming pools and water playgrounds. ...

Scientists make significant discovery in the fight against drug-resistant tuberculosis

September 20, 2018
A team of scientists have identified a naturally occurring antibiotic that may help in the fight against drug-resistant Tuberculosis.

Anti-cancer drugs may hold key to overcoming antimalarial drug resistance

September 20, 2018
Scientists have found a way to boost the efficacy of the world's most powerful antimalarial drug with the help of chemotherapy medicines, according to new research published in the journal Nature Communications.

Affordable Care Act: Study finds surprising gaps in HIV care providers' knowledge

September 20, 2018
A new study has revealed surprising gaps in some HIV medical providers' knowledge of the Affordable Care Act, with more than a quarter of providers surveyed unable to say whether their state had expanded Medicaid.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.